North America Propolis Market Size, Share & Forecast, By Product Type, Application & Distribution Channel, 2026-2031

The North America Propolis Market was valued at USD 244 million in 2025. The estimate covers propolis ingredients and finished consumer products sold through supplements, oral care, personal care, functional foods, and veterinary applications, while avoiding double counting between ingredient transfers and final branded sales. The United States represented the largest country market, supported by high supplement usage, established natural-product retail, and strong e-commerce reach. Capsules and tablets remained the largest product format, but sprays, lozenges, and topical products generated a larger share of recent innovation.

The market is forecast to grow at a 4.10% CAGR from 2026 to 2031, reaching USD 311 million by 2031. Growth is expected to come from approximately 3.1% annual volume expansion and modest realization improvement from premium standardized extracts, direct-to-consumer bundles, oral sprays, and beauty applications. Canada is projected to grow slightly faster than the regional average, while the United States will contribute the largest absolute revenue increase. Forecast risk is concentrated in supply variability, customer acquisition costs, and the credibility of permissible product claims.

Profit will shift toward standardized ingredients, convenient finished formats, and channels that retain customer data. Raw propolis and commodity tinctures face price transparency, while high-polyphenol capsules, alcohol-free sprays, oral-care formulations, and premium topical products can support stronger realization. Digital channels are expected to increase from 28% of category revenue in 2025 to about 38% by 2031, but operators must control marketplace commissions, paid-media costs, returns, and fulfillment. Brands with credible sourcing, documented specifications, and repeat-purchase bundles should capture the most defensible margin expansion.

The most important constraint is inconsistent raw-material chemistry combined with regulated claims and safety obligations. Propolis composition varies by botanical source, region, season, and extraction process, so brands must test identity, strength, contaminants, and stability before making repeatable specifications. U.S. manufacturers must comply with 21 CFR Part 111, while Canadian natural health products require licensing and approved conditions of use. Small brands can underestimate these costs, leading to delayed launches, rejected batches, inconsistent consumer experience, or enforcement exposure when marketing language moves beyond substantiated structure and function claims.

North America is the largest regional market, accounting for 33.6% of global revenue in 2025. The United States is the primary demand hub, while Canada offers higher per-capita category spending and Mexico provides a smaller but strategically relevant pharmacy and apiculture base. Brazil remains a critical competitive and supply benchmark because of green propolis production and ingredient expertise, while European markets retain long-standing consumer familiarity. North America's advantage is retail and digital commercialization; its weakness is dependence on imported botanically differentiated propolis for many premium formulations.

The broad base of supplement users is the most important demand driver because it reduces category-education friction and supports cross-selling. During August 2021-August 2023, 60.2% of U.S. adults used at least one dietary supplement, and 38.7% used two or more. Propolis brands can therefore enter established routines through immune-support, oral-health, beauty, and family-wellness propositions. The strongest growth will not come from awareness alone; it will depend on convenient dosage, credible evidence, taste, alcohol-free options, subscription replenishment, and clear differentiation from honey, echinacea, elderberry, and other natural-health alternatives.